Arformoterol/Budesonide for COVID-19

Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314

NCT04871646 ·Status: UNKNOWN ·Phase: PHASE3

Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients

NCT04393311 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus

NCT04260594 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19

NCT04532931 ·Status: COMPLETED ·Phase: PHASE2

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

NCT04891302 ·Status: COMPLETED ·Phase: PHASE2

Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients

NCT05352347 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

NCT05459532 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

NCT04778059 ·Status: TERMINATED ·Phase: PHASE2

Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19

NCT04619706 ·Status: TERMINATED ·Phase: PHASE2

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

NCT05897541 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

NCT04347915 ·Status: COMPLETED ·Phase: PHASE2

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

NCT05715528 ·Status: COMPLETED ·Phase: PHASE3

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

NCT05033145 ·Status: COMPLETED ·Phase: PHASE3

A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

NCT04522830 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19

NCT05365321 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure

NCT04244591 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia

NCT04254874 ·Status: UNKNOWN ·Phase: PHASE4

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

NCT04595136 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers

NCT04576312 ·Status: COMPLETED ·Phase: PHASE1

A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

NCT04657497 ·Status: COMPLETED ·Phase: PHASE3

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

NCT05689034 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults

NCT01314911 ·Status: COMPLETED ·Phase: NA

Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

NCT04724720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2